Showing results (411-420 of 599) with videos related to
Sort By:
Pageof 60
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.Journal of Autoimmunity|February 5, 2014
International consensus criteria for the diagnosis of Raynaud's phenomenonEmanual Maverakis, Forum Patel, Daniel G Kronenberg, et al.Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.Rheumatology (Oxford, England)|August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standardsDinesh Khanna, Daniel E Furst, Yannick Allanore, et al.Rheumatology (Oxford, England)|November 22, 2022
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysisCorrado Campochiaro, Anna-Maria Hoffmann-Vold, Jerome Avouac, et al.The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.The European Respiratory Journal|July 20, 2019
IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosisAnna Birnhuber, Slaven Crnkovic, Valentina Biasin, et al.Journal of Clinical Medicine|January 11, 2024
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic SclerosisLuna Gargani, Cosimo Bruni, Giancarlo Todiere, et al.The Journal of Rheumatology|May 9, 2008
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label studyAlice Bérezné, Brigitte Ranque, Dominique Valeyre, et al.Rheumatology (Oxford, England)|October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by regionAlain Lescoat, Dörte Huscher, Nils Schoof, et al.Pageof 60